Surface Plasmon Resonance (SPR)

Surface Plasmon Resonance (SPR) is a powerful label-free, real-time biosensing technique that measures molecular interactions by detecting changes in refractive index near a metal-dielectric interface (typically a gold-coated sensor chip). When polarized light strikes the metal surface at a specific angle, it excites surface plasmons—collective oscillations of free electrons—resulting in a dip in reflected light intensity. This "resonance angle" shifts when molecules bind to or dissociate from the sensor surface, allowing precise quantification of binding kinetics (association/dissociation rates) and affinity (equilibrium constants, KD). Unlike fluorescence-based methods, SPR requires no labeling, preserving native molecular behavior and enabling direct analysis of complex biological samples, from small molecules to membrane proteins.

Applications in High-Throughput Screening (HTS)

In the early stages of drug discovery, identifying high-quality hits from vast compound libraries is critical. STEMart leverages SPR technology to accelerate Hit-to-Lead (H2L) optimization by screening interactions between target biomolecules (e.g., receptors, enzymes) and potential drug candidates. SPR's real-time monitoring provides immediate insights into binding specificity, stoichiometry, and thermodynamics, helping prioritize HITs with desirable kinetic profile. For example, in kinase inhibitor development, SPR can distinguish true inhibitors from nonspecific binders, while in antibody discovery, it evaluates antigen-binding affinity and cross-reactivity. By integrating SPR with fragment-based screening, STEMart identifies weak but synthetically tractable fragments, guiding medicinal chemistry efforts to optimize potency and selectivity.

SPR offers unparalleled advantages for HIT screening. Its label-free nature eliminates interference from fluorescent tags or radioactive labels, ensuring data reflect intrinsic molecular properties. The technology's high sensitivity and broad dynamic range accommodate diverse targets, including membrane proteins and low-molecular-weight compounds. Real-time kinetic analysis differentiates between rapid, transient interactions and stable complexes, informing structure-activity relationships (SAR). Additionally, SPR requires minimal sample consumption, reducing costs for precious biologics. Modern SPR systems, like those employed by STEMart, feature high-throughput capabilities (e.g., multi-channel detection, automated sample handling) and support complex matrices (e.g., cell lysates, serum), making them ideal for challenging targets like GPCRs or protein-protein interactions. Combined with advanced data analytics, SPR delivers robust, reproducible results that bridge biochemical assays and cellular studies, de-risking downstream development.

PharmaAnalytica's Technology Platform

PharmaAnalytica's HIT Screening Services with SPR

PharmaAnalytica stands out by combining cutting-edge SPR platforms with deep expertise in drug discovery.

Cutting-Edge SPR Platforms & Expertise

STEMart integrates advanced MI-S2000 Series SPR instruments with deep drug discovery knowledge to deliver reliable, high-throughput screening.

End-to-End HIT Screening Services

From target immobilization (e.g., liposome capture for membrane proteins) to kinetic data analysis, we cover the entire workflow to ensure seamless project execution.

Rigorous QC & Cost Efficiency

Stringent protocols and competitive pricing ensure high reproducibility and affordability.

Client-Centric Decision Support

We empower clients with holistic data interpretation, enabling confident early-stage decisions in drug development.

With SPR's precision and PharmaAnalytica's tailored approach, we transform HIT screening into a strategic asset, accelerating the journey from target validation to clinical candidates.